Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Allisa J Song"'
Autor:
Anita T. Mohan, MBBS, PhD, MBA, Taleen A. MacArthur, MD, Brenna Murphy, MD, Allisa J. Song, BA, Hiba Saifuddin, MD, Amy Degnim, MD, William S. Harmsen, MS, Jorys Martinez-Jorge, MD, James W. Jakub, MD, Aparna Vijayasekaran, MBBS, MSc
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 11, Iss 7, p e5183 (2023)
Background:. The coronavirus disease 2019 (COVID-19) pandemic provoked rapid changes in clinical practice to accommodate mandated restrictions within healthcare delivery. This study reviewed patient-reported experiences and clinical outcomes after im
Externí odkaz:
https://doaj.org/article/f5f5fc00741042b6bf25d5a2b7a16db0
Publikováno v:
The ocular surface. 26
Publikováno v:
European Journal of Ophthalmology. 32:122-128
Purpose: There is an increased risk for development of blepharoptosis after incisional glaucoma surgery. Data on safety and efficacy of ptosis repair in this group of patients in limited. The goal of this study is to evaluate outcomes and identify po
Autor:
Richard D. Palmiter, Allisa J. Song
Publikováno v:
Trends in Genetics. 34:333-340
The Cre-lox recombination approach is commonly used to generate cell-specific gene inactivation (or activation). We have noticed that the breeding and genotyping sections of papers utilizing Cre-lox techniques are frequently incomplete. While seeming
Autor:
Salina D. Johnson, Benjamin B. Land, Allisa J. Song, Kathryn L. Reichard, Harrison M. Fontaine, Charles Chavkin, Joshua H Cohen, Antony D. Abraham, Selena S. Schattauer
Activation of κ opioid receptors (KORs) produces analgesia and aversion via distinct intracellular signaling pathways, but whether G protein-biased KOR agonists can be designed to have clinical utility will depend on a better understanding of the si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b570cfbff6426e163891ed7b1d8020aa
https://europepmc.org/articles/PMC6136151/
https://europepmc.org/articles/PMC6136151/
Nalfurafine is a moderately selective kappa opioid receptor (KOR) analgesic with low incidence of dysphoric side effects in clinical development for the treatment of uremic pruritis. The basis for its reduced dysphoric effect compared to other KOR ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af59ce1721afc67aa1f84cdaa69e89aa
https://europepmc.org/articles/PMC5779083/
https://europepmc.org/articles/PMC5779083/
Autor:
Mackenzie M. Andrews, Brigitte L. Kieffer, Madison A. Baird, Antony D. Abraham, Allisa J. Song, Benjamin B. Land, Charles Chavkin, Harrison M. Fontaine
Publikováno v:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 43(2)
The dynorphin/κ-opioid receptor (KOR) system has been previously implicated in the regulation of cognition, but the neural circuitry and molecular mechanisms underlying KOR-mediated cognitive disruption are unknown. Here, we used an operational test